ReproNovo
Lausanne, Switzerland · Founded 2021 · $62.0M raised
- Headquarters
- Lausanne
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- repronovo.com
- Total Funding
- $62.0M
- Last Round
- $62.0M Series AMay 2025
- Rounds
- 1
About
ReproNovo is a biopharmaceutical company developing innovative therapeutic solutions for reproductive medicine and women's health, including male and female infertility and uterine conditions like adenomyosis. Founded in 2021 and headquartered in Lausanne, Switzerland, the company has two Phase 2 clinical-stage assets: RPN-001 (leflutrozole) for male infertility and RPN-002 (nolasiban) for adenomyosis management and improved IVF outcomes.
Summary
ReproNovo is a Biotech company based in Lausanne, Switzerland, founded in 2021. It has raised $62.0M in total across 1 round, most recently a $62.0M Series A round in May 2025.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2025
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/repronovo"><img src="https://indexed.vc/api/badge/company/repronovo" alt="ReproNovo on Indexed.vc" width="260" height="76" /></a>